Trial Profile
Efficacy of Sofosbuvir in combination with Ribavirin for the treatment of Hepatitis C (GT-2) infection in subjects with Metavir F3/4 fibrosis stage.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 12 May 2016 New trial record
- 17 Apr 2016 Preliminary results (n=143) presented at The International Liver Congress™ 2016